share_log

4: Statement of changes in beneficial ownership of securities-Director TOOVEY STEPHEN

4: Statement of changes in beneficial ownership of securities-Director TOOVEY STEPHEN

4：持股變動聲明-董事 TOOVEY STEPHEN
美股sec公告 ·  05/22 08:25
牛牛AI助理已提取核心訊息
Stephen Toovey, reported a purchase of 4,000 shares of 60 Degrees Pharmaceuticals (SXTP) common stock on May 16, 2024. The transaction was completed at a price of $0.223 per share. Following this acquisition, Toovey's direct holdings in the company increased to a total of 14,000 shares. The transaction, described as a grant, award, or other acquisition, reflects Toovey's growing stake in the pharmaceutical company.
Stephen Toovey, reported a purchase of 4,000 shares of 60 Degrees Pharmaceuticals (SXTP) common stock on May 16, 2024. The transaction was completed at a price of $0.223 per share. Following this acquisition, Toovey's direct holdings in the company increased to a total of 14,000 shares. The transaction, described as a grant, award, or other acquisition, reflects Toovey's growing stake in the pharmaceutical company.
斯蒂芬·圖維報告說，2024年5月16日購買了4,000股60度製藥（SXTP）普通股。該交易以每股0.223美元的價格完成。此次收購後，Toovey在該公司的直接持股量增加到總共14,000股。該交易被描述爲贈款、獎勵或其他收購，反映了Toovey在這家制藥公司的股份不斷增加。
斯蒂芬·圖維報告說，2024年5月16日購買了4,000股60度製藥（SXTP）普通股。該交易以每股0.223美元的價格完成。此次收購後，Toovey在該公司的直接持股量增加到總共14,000股。該交易被描述爲贈款、獎勵或其他收購，反映了Toovey在這家制藥公司的股份不斷增加。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。